After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Affimed N.V. (AFMD) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0046, or -0.89%, to $0.511. The Affimed N.V. has recorded 12,791 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma.
AFMD belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.52 and fluctuated between $0.5354 as its day high and $0.5070 as its day low. The current market capitalization of Affimed N.V. is $77.89M. A total of 0.63 million shares were traded on the day, compared to an average of 929.81K shares.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AFMD in the last 3 months, the mean price target is $5.60 with high estimates of $11.80 and low estimates of $0.91. In terms of 52-week highs and lows, AFMD has a high of $2.80 and a low of $0.45.
As of this writing, AFMD has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.17 per share and a lower estimate of -$0.24. The company reported an EPS of -$0.23 in the last quarter, which was -4.50% lower than expectations of -$0.22.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AFMD’s latest balance sheet shows that the firm has $197.63M in Cash & Short Term Investments as of fiscal 2021. There were $18.69M in debt and $64.55M in liabilities at the time. Its Book Value Per Share was $0.71, while its Total Shareholder’s Equity was $135.95M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AFMD is Buy with a score of 4.75.